A Non-Interventional Study To Describe Early UK Clinical Experience With Linaclotide For Patients With Irritable Bowel Syndrome With Constipation

Trial Profile

A Non-Interventional Study To Describe Early UK Clinical Experience With Linaclotide For Patients With Irritable Bowel Syndrome With Constipation

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Linaclotide (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2016 Primary endpoint (Change from baseline in IBS-Symptom Severity Scale (IBS-SSS) score at 12 weeks) has been met, according to the results presented at the 24th United European Gastroenterology Week
    • 19 Oct 2016 Results presented at the 24th United European Gastroenterology Week
    • 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top